An isoxazole approach to the coleophomones
Coleophomones, metabolites reported first in a Japanese patent in 1998 and then by Merck in 2000 from a Coleophoma fungus, have antifungal and antibacterial properties and inhibit bacterial cell-wall transglycosylase and human heart chymase. Their unique molecular architecture contains a cyclic tric...
Saved in:
| Main Author: | |
|---|---|
| Format: | Default Thesis |
| Published: |
2007
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/11718 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|